clinicalintelpulse.vercel.app
10 listed endpoints · free reliability snapshot (may be up to 24h old)
Base
B 10
endpoints
10
avg trust score
75.9
ecosystem avg 51.7
avg 30-day uptime
94.3%
ecosystem avg 53.5%
avg latency (EU)
638 ms
measured from a single EU vantage point; includes network round-trip distance to the endpoint
price band
$0.1–$0.35
USDC per call
networks
1
At a glance
clinicalintelpulse.vercel.app operates 10 listed x402 endpoints across 1 network. 10 of them carry a computed trust score, averaging 75.9 of 100 (above the ecosystem average of 51.7). Average 30-day uptime across the measured endpoints is 94.3% (above the ecosystem average of 53.5%). Advertised prices range from $0.1 to $0.35 USDC per call. Best-scored endpoint: ClinicalIntelPulse (grade B, 76.2).
Top endpoints by trust score
- ClinicalIntelPulse/api/clinical/sponsor-intelPharma/biotech company pipeline intelligence — full drug pipeline by phase, therapeutic-area coverage, FDA approval history, partnerships, competitive positi…→
- ClinicalIntelPulse/api/clinical/approval-outlookFDA/EMA drug approval probability + PDUFA calendar for a disease area — which Phase 3 drugs are most likely to win approval in 12-24 months, with mechanism,…→
- ClinicalIntelPulse/api/clinical/disease-landscapeCompetitive drug pipeline landscape for any disease — full Phase 2/3 trial map, mechanism-of-action coverage, approved drugs, PDUFA calendar, M&A activity, o…→
- ClinicalIntelPulse/api/clinical/pipeline-scanClinical trial pipeline scan for any disease — all active Phase 2/3 trials with trial counts, sponsor landscape, geographic distribution, mechanism breakdown…→
- ClinicalIntelPulse/api/clinical/patient-finderRecruiting clinical trial finder for a disease or diagnosis — actively recruiting trials with plain-language summaries, eligibility (who can/cannot join), co…→
All endpoints
| endpoint▼ | grade▼ | uptime 30d▼ | conf.▼ | price▼ |
|---|---|---|---|---|
| /api/clinical/patient-finder ClinicalIntelPulse | B 75.8 | 94.2% | 1.00 | $0.1 |
| /api/clinical/trial-brief ClinicalIntelPulse | B 75.6 | 93.4% | 1.00 | $0.1 |
| /api/clinical/disease-landscape ClinicalIntelPulse | B 76.1 | 94.7% | 1.00 | $0.35 |
| /api/clinical/deal-signal ClinicalIntelPulse | B 75.8 | 94.0% | 1.00 | $0.35 |
| /api/clinical/failure-analysis ClinicalIntelPulse | B 75.7 | 93.9% | 1.00 | $0.2 |
| /api/clinical/global-trials ClinicalIntelPulse | B 75.7 | 94.0% | 1.00 | $0.15 |
| /api/clinical/mechanism-map ClinicalIntelPulse | B 75.8 | 93.9% | 1.00 | $0.2 |
| /api/clinical/sponsor-intel ClinicalIntelPulse | B 76.2 | 95.2% | 1.00 | $0.2 |
| /api/clinical/pipeline-scan ClinicalIntelPulse | B 76.0 | 94.5% | 1.00 | $0.15 |
| /api/clinical/approval-outlook ClinicalIntelPulse | B 76.2 | 95.0% | 1.00 | $0.25 |
Scores use reduced-density sampling; live probe, full 30-min density and 90-day history via the paid API. Provider-supplied names and descriptions are unverified claims; the grades are our independent measurement.